Basic Information
ID: ALA696421
Type: Functional
Description: Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
Tissue: Plasma
Activity Charts
Bioactivity
Activity Types for Assay ALA696421
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 256.09 | 1.93 | 1.93 |
| 384.48 | 2.57 | 2.57 |
| 299.33 | 2.65 | 2.65 |
| 366.47 | 3.93 | 3.93 |
| 380.49 | 4.27 | 4.27 |
| 285.30 | 2.57 | 2.57 |
| 311.31 | 1.29 | 1.29 |
| 268.28 | 2.45 | 2.45 |
| 287.28 | 2.01 | 2.01 |
| 213.24 | 2.39 | 2.39 |
| 329.36 | 2.88 | 2.88 |
| 315.33 | 1.67 | 1.67 |
| 315.33 | 2.16 | 2.16 |
| 301.30 | 2.40 | 2.40 |
| 325.33 | 1.68 | 1.68 |
| 315.33 | 2.49 | 2.49 |
| 410.52 | 4.17 | 4.17 |
| 424.55 | 4.56 | 4.56 |
| 410.52 | 4.50 | 4.50 |
| 426.47 | 3.17 | 3.17 |
| 454.53 | 3.65 | 3.65 |
| 426.47 | 2.73 | 2.73 |
| 352.44 | 3.49 | 3.49 |
| 440.50 | 3.26 | 3.26 |
| 418.54 | 4.57 | 4.57 |
| 289.29 | 0.86 | 0.86 |
| 287.32 | 2.31 | 2.31 |
| 398.42 | 2.25 | 2.25 |
| 301.30 | 2.07 | 2.07 |
| 397.46 | 3.40 | 3.40 |
| 275.26 | 0.50 | 0.50 |
| 273.29 | 1.92 | 1.92 |
| 396.49 | 3.78 | 3.78 |
| 410.52 | 4.50 | 4.50 |
| 354.41 | 2.94 | 2.94 |
| 420.51 | 4.01 | 4.01 |
| 396.49 | 4.11 | 4.11 |
| 382.46 | 3.77 | 3.77 |
| 382.46 | 3.72 | 3.72 |
| 314.35 | 2.02 | 2.02 |
| 300.32 | 1.67 | 1.67 |
| 286.29 | 1.41 | 1.41 |
| 382.46 | 3.44 | 3.44 |
| 245.24 | 1.14 | 1.14 |